Skip to main content
SpringerLink
Log in

Adalimumab/infliximab/purines

Squamous cell carcinoma, basal cell carcinoma and malignant melanoma: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Mack A, et al. Low rates of skin cancer screening and detection in patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology 35 (Suppl.): 111, Nov 2020. Available from: URL: http://doi.org/10.1111/jgh.15271 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/infliximab/purines. Reactions Weekly 1847, 22 (2021). https://doi.org/10.1007/s40278-021-92579-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-92579-2

Search

Navigation